Javascript must be enabled to continue!
Some studies with a monoclonal antibody directed against human fibrinogen
View through CrossRef
AbstractSome properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated. The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease. It reacted in a sensitive immunoassay of plasma fibrinogen. The specificity of the antibody was confined to the parent molecule with no significant inhibition of fibrinogen binding by the fibrinogen degradation products (FDPs) X, Y, D, or E. The antibody had no significant effect on the activated partial thromboplastin time and prothrombin time of normal plasma. However, it prolonged the thrombin time as determined by the Clauss chronometric fibrinogen method. During fibrinogen lysis by plasmin immunoreactivity of fibrinogen to the antibody was lost at the same rate as the clottable fibrinogen content determined by the Clauss assay. The lack of reactivity of the antibody with FDPs makes it a suitable reagent for investigating plasmin activity as well as studying fibrinogen and fibrin. These findings suggest that the epitope of the antibody lies within the polar protruberance of the carboxy terminal end of the Aα chain of fibrinogen and is destroyed by plasmin cleavage.
Title: Some studies with a monoclonal antibody directed against human fibrinogen
Description:
AbstractSome properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated.
The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease.
It reacted in a sensitive immunoassay of plasma fibrinogen.
The specificity of the antibody was confined to the parent molecule with no significant inhibition of fibrinogen binding by the fibrinogen degradation products (FDPs) X, Y, D, or E.
The antibody had no significant effect on the activated partial thromboplastin time and prothrombin time of normal plasma.
However, it prolonged the thrombin time as determined by the Clauss chronometric fibrinogen method.
During fibrinogen lysis by plasmin immunoreactivity of fibrinogen to the antibody was lost at the same rate as the clottable fibrinogen content determined by the Clauss assay.
The lack of reactivity of the antibody with FDPs makes it a suitable reagent for investigating plasmin activity as well as studying fibrinogen and fibrin.
These findings suggest that the epitope of the antibody lies within the polar protruberance of the carboxy terminal end of the Aα chain of fibrinogen and is destroyed by plasmin cleavage.
Related Results
KADAR FIBRINOGEN SEBAGAI FAKTOR PROGNOSTIK PASIEN PERDARAHAN INTRASEREBRAL SPONTAN
KADAR FIBRINOGEN SEBAGAI FAKTOR PROGNOSTIK PASIEN PERDARAHAN INTRASEREBRAL SPONTAN
FIBRINOGEN VALUE AS PROGNOSTIC FACTOR IN SPONTANEOUS INTRACEREBRAL HEMORRHAGEABSTRACTIntroduction: Spontaneous intracerebral haemorrhage (SIH) refers as spontaneous bleedi...
Fibrinogen Heterogeneity in Homozygous Plasminogen Deficiency Type I: Further Evidence that Plasmin Is not Involved in Formation of LMW- and LMW’-Fibrinogen
Fibrinogen Heterogeneity in Homozygous Plasminogen Deficiency Type I: Further Evidence that Plasmin Is not Involved in Formation of LMW- and LMW’-Fibrinogen
SummaryHuman plasma fibrinogen is heterogeneous in SDS-polyacrylamide gel electrophoresis and other methods for separation of proteins by molecular size. A high molecular weight fr...
Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: A cross-sectional observational study
Fibrinogen; a predictor of injury severity and mortality among patients with traumatic brain injury in Sub-Saharan Africa: A cross-sectional observational study
Studies show that fibrinogen concentrations <2 g/L in patients with traumatic brain injury (TBI) is associated with increased mortality. However, little is known regarding fibri...
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
Complement C3 binds fibrinogen and compromises fibrin clot lysis thereby enhancing thrombosis risk. We investigated the role of fibrinogen-C3 interaction as a novel therapeutic tar...
Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces
Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces
In addition to preserving hemostasis, fibrinogen assembly on leukocytes mediates inflammatory responses and may aberrantly contribute to vascular injury. In this study, we used rea...
The TEMPI syndrome: Unique patient specific monoclonal antibodies as tools for target antigen discovery
The TEMPI syndrome: Unique patient specific monoclonal antibodies as tools for target antigen discovery
Abstract
BACKGROUND. In 2011, we discovered the TEMPI syndrome. TEMPI is a rare monoclonal gammopathy of clinical signif...
Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors
Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors
Abstract
The effect of human fibrinogen on the proliferation of purified SBA- CD34+ human bone marrow progenitors was investigated in clonal cultures. Fibrinogen alo...
Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors
Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors
The effect of human fibrinogen on the proliferation of purified SBA- CD34+ human bone marrow progenitors was investigated in clonal cultures. Fibrinogen alone or in combination wit...

